[Effect of interferon-alpha (MOR-22) on human NK cell activity]

Area of Science:

• Immunology
• Virology
• Oncology

Context:

• Natural killer (NK) cells are crucial for innate immunity against viral infections and tumors.
• Interferon-alpha (IFN-alpha) is a cytokine with known immunomodulatory and anti-tumor properties.
• The precise mechanisms by which IFN-alpha enhances NK cell activity are not fully elucidated.

Purpose:

• To investigate the effect of human lymphoblastoid interferon-alpha (IFN-alpha) on the cytotoxic activity of human peripheral blood lymphocytes (PBL) NK cells.
• To determine the dose- and time-dependency of IFN-alpha-induced NK cell activation.
• To characterize the spectrum of tumor cell lines sensitive to IFN-alpha-activated NK cells and identify the NK cell subset involved.

Summary:

• Pretreatment of human PBL with IFN-alpha (MOR-22) significantly augmented NK cell activity against K562 target cells by an average of 3.8-fold at 1,000 IU/ml for 2 hours.
• NK cell augmentation was observed with IFN-alpha concentrations as low as 10 IU/ml for 2 hours or 1,000 IU/ml for 30 minutes.
• The enhanced NK cell activity exhibited a broad cytotoxic spectrum against various human tumor cell lines, independent of their origin or IFN-alpha's antiproliferative effects.
• NK cell activation by IFN-alpha appears to involve the Leu-11 positive NK cell subset, as evidenced by near-complete depletion of activity after anti-Leu-11b antibody and complement treatment.

Impact:

• These findings suggest that IFN-alpha-mediated activation of NK cells, particularly the Leu-11 positive subset, plays a significant role in the anti-tumor efficacy of interferon therapy.
• Understanding this mechanism could lead to improved therapeutic strategies combining interferon and NK cell-based immunotherapies for cancer treatment.